Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Northwest Medical Specialties provides comprehensive cancer care and participates in over 40 active phase I–III oncology clinical trials. It recently launched a Theranostics Program leveraging nuclear medicine for precision diagnosis and targeted therapy. The organization has been recognized for quality initiatives and maintains exemplary audit results with sponsors.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Northwest Medical Specialties.